Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $1,125,983 (99.5% shares, 0.5% debt)

Holdings (17)

VTI VANGUARD INDEX FDS 21.3%
Value ($000) $239,927 Shares 2,155,100 Est. Cost $57.39 Unrealized
INGN INOGEN INC 18.9%
Value ($000) $212,604 Shares 3,549,320 Est. Cost $17.78 Unrealized +213.4%
OPHTHOTECH CORP 14.8%
Value ($000) $166,552 Shares 3,610,487 Est. Cost $32.35 Unrealized
COLUCID PHARMACEUTICALS INC 10.7%
Value ($000) $120,423 Shares 3,156,563 Est. Cost $9.83 Unrealized
VGK VANGUARD INTL EQUITY INDEX F 9.1%
Value ($000) $102,382 Shares 2,101,000 Est. Cost $45.01 Unrealized
REATA PHARMACEUTICALS INC 7.9%
Value ($000) $88,774 Shares 3,367,763 Est. Cost $19.75 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 4.7%
Value ($000) $53,036 Shares 3,224,046 Est. Cost $14.33 Unrealized +0.6%
ACCELERON PHARMA INC 2.9%
Value ($000) $32,710 Shares 903,833 Est. Cost $28.86 Unrealized
SPECTRANETICS CORP 2.6%
Value ($000) $28,997 Shares 1,155,722 Est. Cost $18.07 Unrealized
MERUS N V 2.1%
Value ($000) $23,624 Shares 1,410,417 Est. Cost $7.99 Unrealized
FLEXION THERAPEUTICS INC 1.9%
Value ($000) $21,449 Shares 1,097,718 Est. Cost $15.58 Unrealized
INVUITY INC 1.6%
Value ($000) $17,636 Shares 1,285,448 Est. Cost $9.68 Unrealized
NABRIVA THERAPEUTICS AG 0.7%
Value ($000) $7,872 Shares 1,116,660 Est. Cost $9.04 Unrealized
WRIGHT MED GROUP N V 0.5%
Value ($000) $6,055 Shares 4,622,032 Est. Cost $1.25 Unrealized
HTG MOLECULAR DIAGNOSTICS INC 0.3%
Value ($000) $2,906 Shares 1,280,185 Est. Cost $11.15 Unrealized
XENE XENON PHARMACEUTICALS INC 0.1%
Value ($000) $1,033 Shares 127,563 Est. Cost $14.68 Unrealized -47.4%
OPK OPKO HEALTH INC 0.0%
Value ($000) $3 Shares 259 Est. Cost $9.96 Unrealized 0.0%